vs
Arcutis Biotherapeutics, Inc.（ARQT）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
Arcutis Biotherapeutics, Inc.的季度营收约是RESOURCES CONNECTION, INC.的1.1倍（$129.5M vs $117.7M），Arcutis Biotherapeutics, Inc.净利率更高（13.4% vs -10.8%，领先24.2%），Arcutis Biotherapeutics, Inc.同比增速更快（81.5% vs -19.2%），过去两年Arcutis Biotherapeutics, Inc.的营收复合增速更高（61.6% vs -11.8%）
Arcutis Biotherapeutics是一家临床阶段生物制药企业，专注于开发和商业化免疫介导皮肤病领域的创新处方疗法，产品管线覆盖银屑病、特应性皮炎、斑秃等适应症，主要服务美国市场的患者及医疗服务提供者，填补皮肤科诊疗领域的未满足需求。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
ARQT vs RGP — 直观对比
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $129.5M | $117.7M |
| 净利润 | $17.4M | $-12.7M |
| 毛利率 | 91.0% | 37.1% |
| 营业利润率 | 14.2% | -10.3% |
| 净利率 | 13.4% | -10.8% |
| 营收同比 | 81.5% | -19.2% |
| 净利润同比 | 261.2% | 81.6% |
| 每股收益（稀释后） | $0.14 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $129.5M | $117.7M | ||
| Q3 25 | $99.2M | $120.2M | ||
| Q2 25 | $81.5M | $139.3M | ||
| Q1 25 | $65.8M | $129.4M | ||
| Q4 24 | $71.4M | $145.6M | ||
| Q3 24 | $44.8M | $136.9M | ||
| Q2 24 | $30.9M | $148.2M | ||
| Q1 24 | $49.6M | $151.3M |
| Q4 25 | $17.4M | $-12.7M | ||
| Q3 25 | $7.4M | $-2.4M | ||
| Q2 25 | $-15.9M | $-73.3M | ||
| Q1 25 | $-25.1M | $-44.1M | ||
| Q4 24 | $-10.8M | $-68.7M | ||
| Q3 24 | $-41.5M | $-5.7M | ||
| Q2 24 | $-52.3M | $10.5M | ||
| Q1 24 | $-35.4M | $2.5M |
| Q4 25 | 91.0% | 37.1% | ||
| Q3 25 | 91.2% | 39.5% | ||
| Q2 25 | 90.8% | 40.2% | ||
| Q1 25 | 86.6% | 35.1% | ||
| Q4 24 | 90.3% | 38.5% | ||
| Q3 24 | 87.7% | 36.5% | ||
| Q2 24 | 88.8% | 40.2% | ||
| Q1 24 | 93.4% | 37.0% |
| Q4 25 | 14.2% | -10.3% | ||
| Q3 25 | 8.6% | -1.7% | ||
| Q2 25 | -17.9% | -47.0% | ||
| Q1 25 | -37.3% | -38.4% | ||
| Q4 24 | -10.7% | -52.7% | ||
| Q3 24 | -87.3% | -3.5% | ||
| Q2 24 | -162.3% | 7.6% | ||
| Q1 24 | -63.8% | 2.8% |
| Q4 25 | 13.4% | -10.8% | ||
| Q3 25 | 7.5% | -2.0% | ||
| Q2 25 | -19.5% | -52.6% | ||
| Q1 25 | -38.1% | -34.0% | ||
| Q4 24 | -15.1% | -47.2% | ||
| Q3 24 | -92.8% | -4.2% | ||
| Q2 24 | -169.6% | 7.1% | ||
| Q1 24 | -71.4% | 1.7% |
| Q4 25 | $0.14 | $-0.38 | ||
| Q3 25 | $0.06 | $-0.07 | ||
| Q2 25 | $-0.13 | $-2.21 | ||
| Q1 25 | $-0.20 | $-1.34 | ||
| Q4 24 | $-0.09 | $-2.08 | ||
| Q3 24 | $-0.33 | $-0.17 | ||
| Q2 24 | $-0.42 | $0.31 | ||
| Q1 24 | $-0.32 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.9M | $89.8M |
| 总债务越低越好 | $109.0M | — |
| 股东权益账面价值 | $189.5M | $194.6M |
| 总资产 | $433.0M | $289.3M |
| 负债/权益比越低杠杆越低 | 0.58× | — |
8季度趋势，按日历期对齐
| Q4 25 | $42.9M | $89.8M | ||
| Q3 25 | $47.1M | $77.5M | ||
| Q2 25 | $72.7M | $86.1M | ||
| Q1 25 | $53.1M | $72.5M | ||
| Q4 24 | $71.3M | $78.2M | ||
| Q3 24 | $134.9M | $89.6M | ||
| Q2 24 | $84.3M | $108.9M | ||
| Q1 24 | $190.1M | $113.8M |
| Q4 25 | $109.0M | — | ||
| Q3 25 | $108.5M | — | ||
| Q2 25 | $108.0M | — | ||
| Q1 25 | $107.6M | — | ||
| Q4 24 | $107.2M | — | ||
| Q3 24 | $204.6M | — | ||
| Q2 24 | $203.8M | — | ||
| Q1 24 | $202.8M | — |
| Q4 25 | $189.5M | $194.6M | ||
| Q3 25 | $158.1M | $206.4M | ||
| Q2 25 | $139.0M | $207.1M | ||
| Q1 25 | $142.7M | $277.8M | ||
| Q4 24 | $157.5M | $325.7M | ||
| Q3 24 | $156.6M | $407.2M | ||
| Q2 24 | $186.4M | $418.8M | ||
| Q1 24 | $224.9M | $414.9M |
| Q4 25 | $433.0M | $289.3M | ||
| Q3 25 | $371.0M | $287.2M | ||
| Q2 25 | $352.4M | $304.7M | ||
| Q1 25 | $344.1M | $375.6M | ||
| Q4 24 | $348.9M | $424.9M | ||
| Q3 24 | $437.4M | $512.9M | ||
| Q2 24 | $444.8M | $510.9M | ||
| Q1 24 | $478.5M | $523.2M |
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 1.31× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 0.90× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.2M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | — | $15.6M |
| 自由现金流率自由现金流/营收 | — | 13.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | $24.3M |
8季度趋势，按日历期对齐
| Q4 25 | $26.2M | $15.9M | ||
| Q3 25 | $-1.8M | $-7.8M | ||
| Q2 25 | $324.0K | $16.8M | ||
| Q1 25 | $-30.4M | $659.0K | ||
| Q4 24 | $-748.0K | $1.8M | ||
| Q3 24 | $-34.7M | $-309.0K | ||
| Q2 24 | $-45.1M | $3.2M | ||
| Q1 24 | $-31.6M | $20.5M |
| Q4 25 | — | $15.6M | ||
| Q3 25 | — | $-8.0M | ||
| Q2 25 | $246.0K | $16.5M | ||
| Q1 25 | $-31.0M | $238.0K | ||
| Q4 24 | — | $61.0K | ||
| Q3 24 | $-34.8M | $-575.0K | ||
| Q2 24 | — | $3.0M | ||
| Q1 24 | — | $20.4M |
| Q4 25 | — | 13.2% | ||
| Q3 25 | — | -6.6% | ||
| Q2 25 | 0.3% | 11.8% | ||
| Q1 25 | -47.1% | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | -77.8% | -0.4% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.9% | 0.3% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.3% | 0.2% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.1% |
| Q4 25 | 1.51× | — | ||
| Q3 25 | -0.24× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARQT
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
